MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.

MLA

Li, Yufeng, et al. “MART-1-Specific Melanoma Tumor-Infiltrating Lymphocytes Maintaining CD28 Expression Have Improved Survival and Expansion Capability Following Antigenic Restimulation in Vitro.” Journal of Immunology (Baltimore, Md. : 1950), vol. 184, no. 1, Jan. 2010, pp. 452–65. EBSCOhost, https://doi.org/10.4049/jimmunol.0901101.

APA

Li, Y., Liu, S., Hernandez, J., Vence, L., Hwu, P., & Radvanyi, L. (2010). MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro. Journal of Immunology (Baltimore, Md. : 1950), 184(1), 452–465. https://doi.org/10.4049/jimmunol.0901101

Chicago

Li, Yufeng, Shujuan Liu, Jessica Hernandez, Luis Vence, Patrick Hwu, and Laszlo Radvanyi. 2010. “MART-1-Specific Melanoma Tumor-Infiltrating Lymphocytes Maintaining CD28 Expression Have Improved Survival and Expansion Capability Following Antigenic Restimulation in Vitro.” Journal of Immunology (Baltimore, Md. : 1950) 184 (1): 452–65. doi:10.4049/jimmunol.0901101.